|
|
|
Description du produit |
|
|
|
|
|
Information sur le fabricant
|
.
Product Name:
Diazapam
Synonyms:
1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one;2H-1,4-Benzodiazepin-2-one,7-chloro-1,3-dihydro-1-methyl-5-phenyl-;2H-1,4-Benzodiazepine-2-one,7-chloro-1,3-dihydro-1-methyl-5-phenyl-;7-chloro-1,3-dihydro-1-methyl-5-phenyl-2h-4-benzodiazepin-2-one;7-Chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepine;7-Chloro-1-methyl-5-3H-1,4-benzodiazepin-2(1H)-one;7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one;7-Chloro-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
CAS:
439-14-5
MF:
C16H13ClN2O
MW:
284.74
EINECS:
207-122-5
Product Categories:
Miscellaneous Biochemicals;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Benzodiazepin Analoga StructureAlphabetic;DIA - DICForensic and Veterinary Standards;Chemical Structure;D;Drugs of Abuse;Drugs&Metabolites;Solutions
Mol File:
439-14-5.mol
|
|
|
D'autres marchandises de ce producteur : |
|
|
|
|
|
Name:
5,8-Dihydro-5-aethyl-8-oxofuro(3,2-b)(1,8)naphthyridin-7-carbonsaeure [German]
CAS No.:
73101-87-8
Molecular Structure
|
| |
|
|
Name:
Benzene,1,1'-(chlorophenylmethylene)bis[4-methoxy-
CAS No.:
40615-36-9
Molecular Structure:
|
| |
|
|
(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE Basic information
Product Name:
(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE
|
|
|
|
|
ACD/LogP:
7.070.82
# of Rule of 5Violations:
1
ACD/LogD (pH 5.5):
7.07
ACD/LogD (pH 7.4
|
| |
|
|
name EG018
CAS number 983123-31-2
color white
delivery time within 3 days after receivng your deposite
payment terms t/t or western union
|
| |
|
|
Preview
CBNumber:
CB9918528
Chemical Name:
elymoclavin
|
|
|
|
|
1.Best quality in your requirement
2.Competitive price in China market
3.mature Technical support
4.Professional logistic&nb
|
| |
|
|
Preview
CBNumber:
CB2341484
Chemical Name:
EPHEDRINE
|
| |
|
|
Basic Information
Name:
Ergoline-8-carboxamide,9,10-didehydro-N-[(1S)-2-hydroxy-1-methylethyl]-6-methyl-, (8b)-
CAS No.:
60-79
|
|
|
|
|
|
|
|
|
|
|
|